Nautilus Biotechnology, Inc. Annual Operating Lease, Payments in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Nautilus Biotechnology, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2020 to 2024.
  • Nautilus Biotechnology, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.7M, a 41.7% increase year-over-year.
  • Nautilus Biotechnology, Inc. annual Operating Lease, Payments for 2024 was $7M, a 12.9% increase from 2023.
  • Nautilus Biotechnology, Inc. annual Operating Lease, Payments for 2023 was $6.2M, a 59% increase from 2022.
  • Nautilus Biotechnology, Inc. annual Operating Lease, Payments for 2022 was $3.9M, a 117% increase from 2021.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $7M +$800K +12.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $6.2M +$2.3M +59% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $3.9M +$2.1M +117% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $1.8M -$200K -10% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-23
2020 $2M Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.